Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
1501 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 43
1502 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 74
1503 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
1504 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 59
1505 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 66
1506 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
1507 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 33
1508 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 48
1509 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Netherlands 66
1510 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 57
1511 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 56
1512 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
1513 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 24
1514 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 61
1515 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
1516 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 53
1517 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 62
1518 Apheresis Autologous Mantle Cell Lymphoma Hematology 2025 Standard Therapy Germany 45
1519 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 61
1520 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 32
1521 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2025 Standard Therapy Germany 62
1522 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 75
1523 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 70
1524 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 6
1525 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
1526 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 4
1527 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
1528 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 50,3
1529 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 49,5
1530 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 58,11
1531 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 7,7
1532 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 15,7
1533 Cord Tissue Allogeneic – Unrelated Ovarian Dysfunction Gynecology 2024 Experimental Therapy Poland 48,1
1534 Cord Tissue Allogeneic – Related Severe Pulmonary Hypertension +Mitral Regurgitation Cardiovascular/Pulmonary 2024 Experimental Therapy Romania 2,6
1535 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 57,6
1536 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 68,2
1537 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 17
1538 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 7
1539 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 61,9
1540 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 45,4
1541 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 56,9
1542 Cord Tissue Allogeneic – Unrelated Graft-versus-host disease Hematology 2024 Experimental Therapy Poland 0,10
1543 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 39,0
1544 Cord Tissue Allogeneic – Unrelated GvHD Neurology 2024 Experimental Therapy Poland 9,2
1545 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 5,11
1546 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 13,10
1547 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1,9
1548 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2024 Experimental Therapy Poland 7,11
1549 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1
1550 Cord Tissue Allogeneic – Unrelated Cerebellar-spinal ataxia Neurology 2024 Experimental Therapy Poland 35,5
1551 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1,9
1552 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2024 Experimental Therapy Poland 4,5
1553 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 11
1554 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 10
1555 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 6
1556 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 4
1557 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 5
1558 Cord Blood Allogeneic Cerebral Palsy Neurology 2024 Experimental Therapy Poland 3,5
1559 Cord Blood Allogeneic Cerebral Palsy Neurology 2024 Experimental Therapy Poland 7,7
1560 Cord Blood Autologous CP Neurology 2024 Experimental Therapy Hungary 4
1561 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2024 Experimental Therapy Poland 3,7
1562 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2024 Experimental Therapy Poland 5,9
1563 Cord Blood Autologous Pervasive developmental disorder Neurology 2024 Experimental Therapy Poland 4,8
1564 Cord Blood Allogeneic – Related fanconi aplastic anemia Hematology 2024 Standard Therapy Turkey 12
1565 Cord Blood Autologous Neuroblastoma Neurology 2024 Standard Therapy Poland 4
1566 Cord Blood Autologous Pervasive developmental disorder Neurology 2024 Experimental Therapy Poland 9,9
1567 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Slovakia 4
1568 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1569 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 70
1570 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 75
1571 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 56
1572 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 23
1573 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 54
1574 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1575 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 70
1576 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 65
1577 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 48
1578 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2024 Standard Therapy Germany 72
1579 Bone Marrow Family Allogeneic Chronic Lymphocytic Leukemia Richter Transformation Hematology 2024 Standard Therapy Poland 55
1580 Bone Marrow Family Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 63
1581 Bone Marrow Family Allogeneic Follicular Lymphoma Hematology 2024 Standard Therapy Poland 48
1582 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 65
1583 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 58
1584 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 70
1585 Bone Marrow Family Allogeneic Myelodysplastic Syndrome – Refractory Cytopenia Of Childhood Hematology 2024 Standard Therapy Poland 14
1586 Bone Marrow Family Allogeneic Myelodysplastic Syndrome/ Myeloproliferative Neoplasms Hematology 2024 Standard Therapy Germany 61
1587 Bone Marrow Family Allogeneic Myelodysplastic Syndrome-MPN Hematology 2024 Standard Therapy Poland 71
1588 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2024 Standard Therapy Poland 68
1589 Bone Marrow Family Allogeneic Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 64
1590 Bone Marrow Family Allogeneic Polycythemia Vera/Myelofibrosis Hematology 2024 Standard Therapy Poland 74
1591 Bone Marrow Family Allogeneic Primary Myelofibrosis Hematology 2024 Standard Therapy Germany 62
1592 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 68
1593 Bone Marrow Family Allogeneic Myelodysplasia Hematology 2024 Standard Therapy United Kingdom 57
1594 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 69
1595 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 58
1596 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 60
1597 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 71
1598 Bone Marrow Family Allogeneic High risk Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 69
1599 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 74
1600 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 15